Pharmalot... Pharmalittle... Good Morning

Good morning, everyone, and how are you today? Cloudy skies are again hovering over the Pharmalot corporate campus, but as you know, we are reminded to maintain sunny spirits thanks to the Morning Mayor, who taught us that 'every day should be unwrapped like a precious gift.' And so, time to celebrate with a cup of stimulation and a few interesting tidbits. Hope you find these helpul and that you have a great day. Be in touch...

Pfizer Appeal Over Whistleblowing Scientist To Be Heard Today (The Day)

Oxfam Slams 'Risky' Malaria Drug Distribution (Pharma Times)

Cancer Patient Hopes For Chemo May Be Too High (Reuters)

India Seeks Legal Review Of Pricing Proposal (Economic Times)

Ukraine Import Laws Spur Hopes For Trials (Outsourcing Pharma)

Hormone Use After Menopause Start May Reduce Dementia (Bloomberg News)

Quintiles To Run Its First Global Trial With Indonesians (Outsourcing Pharma)

EU Approves Pfizer Xalkori Lung Cancer Drug (Pharma Times)

EDITOR'S NOTE: Please check this post for updates

4 Comments

Oct 25, 2012 - 10:03am
Hi Ed, What's going on here?

"Page Not Found. Error 404 http://www.pharmalot.com/2012/10/pharmalot-pharmalittle-good-morning-696/us-cancer-patients-idUSBRE89N1M220121025 You might have typed in the wrong url, so give it another try. If that doesn't work, you might have better luck searching our archives. -Pharmalot"

I'd like to read this article if you can repair the link or repost it in a new link.

Thanks much, Arlene Teck

Hi Arlene,

Thanks for letting me know. I just fixed the link. Sorry for the inconvenience.

Best ed

Oct 25, 2012 - 2:13pm
Hi Ed,

The Reuters link is working fine now.

Thanks for the fix, Arlene

In regards to the Reuter's article, Cancer Patient Hopes For Chemo May Be Too High, it's the oncology community's failure to offer better cancer therapy. The treatment armamentarium for this disease is relatively poor. We need more effective drugs.

So now the emphasis is on chronic disease, or in this case, palliative intent, delaying progression of the disease rather than on eliminating it altogether, by "juggling" the order of the chemotherapies used.

To me, that seems like more of the same "trial-and-error" therapy we've grown so accustomed to. It's a cop-out, anyway you think of it.